Login / Signup

'Minimal symptom expression' in patients with acetylcholine receptor antibody-positive refractory generalized myasthenia gravis treated with eculizumab.

John VissingSaiju JacobKenji P FujitaFanny L O'BrienJames F Howardnull null
Published in: Journal of neurology (2020)
ClinicalTrials.gov NCT01997229, NCT02301624.
Keyphrases
  • myasthenia gravis
  • poor prognosis
  • binding protein
  • long non coding rna
  • newly diagnosed